Description
T2 is a synthetic dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 receptor. This combined receptor activity is of growing interest in research assessing metabolic regulation, glucose control, and adipose tissue dynamics.
In vitro and preclinical studies explore T2 ability to influence insulin sensitivity, lipid metabolism, appetite-related pathways, and body weight regulation. Its dual incretin receptor engagement provides a unique mechanism for examining how T2 signaling together may affect energy balance, glycemic stability, and reductions in both subcutaneous and visceral adipose tissue.
T3 is commonly evaluated in metabolic research models focused on obesity, insulin resistance, and multi-pathway peptide therapeutics.
• • • • • • • • • • • • • • • PLEASE READ • • • • • • • • • • • • • • •
RESEARCH USE ONLY DISCLAIMER AND LIMITATION OF LIABILITY
All articles, materials, content, and product-related information made available on this website are provided strictly for informational and educational purposes only and shall not be construed as medical, pharmaceutical, clinical, or therapeutic advice, nor as a representation of safety or efficacy for any human or animal use.
These products are not drugs, pharmaceuticals, biologics, medical devices, dietary supplements, food products, or cosmetics, and they have not been evaluated, approved, or authorized by the United States Food and Drug Administration (FDA) or any other regulatory authority for human or animal use.
The Company reserves all rights and expressly disclaims any liability arising from misuse, improper handling, or unauthorized application of its products.
Additional information
| WEIGHT (mg) | 10mg |
|---|---|
| PURITY LEVEL | ≥ 99% + |
| CERTIFICATE OF ANALYSIS | HPLC US Certified |
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.